NCT05701943 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Borrega-Mouquinho Y, Sanchez-Gomez J, Fuentes-Garcia JP, Collado-Mateo D, Villafaina S
Effects of High-Intensity Interval Training and Moderate-Intensity Training on Stress, Depression, Anxiety, and Resilience in Healthy Adults During Coronavirus Disease 2019 Confinement: A Randomized Controlled Trial. Front Psychol. 2021 Feb 24;12:643069. doi: 10.3389/fpsyg.2021.643069. eCollection 2021.
Oviedo GR, Guerra-Balic M, Baynard T, Javierre C
Effects of aerobic, resistance and balance training in adults with intellectual disabilities. Res Dev Disabil. 2014 Nov;35(11):2624-34. doi: 10.1016/j.ridd.2014.06.025. Epub 2014 Jul 18.
Oviedo GR, Javierre C, Font-Farre M, Tamulevicius N, Carbo-Carrete M, Figueroa A, Perez-Testor S, Cabedo-Sanroma J, Moss SJ, Masso-Ortigosa N, Guerra-Balic M
Intellectual disability, exercise and aging: the IDEA study: study protocol for a randomized controlled trial. BMC Public Health. 2020 Aug 20;20(1):1266. doi: 10.1186/s12889-020-09353-6.
Riebe, D
, et al., ACSM's guidelines for exercise testing and prescription. 10th ed. 2018, Philadelphia.

Home- vs Gym-based Exercise Delivery Modes of Two Aerobic Training Regimes on Cardiorespiratory Fitness and Arterial Stiffness in Adults With Intellectual and Developmental Disability During the COVID-19 Pandemic

Details for clinical trial NCT05701943

Clinical trial NCT05701943 - References